Hennion & Walsh Asset Management’s Cogent Biosciences COGT Stock Holding History

Hennion & Walsh Asset Management’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.1M	Sell	131,775 -194,697	-60%	-$6.81M	0.15%	189
2026 Q1	$12.6M	Sell	326,472 -11,593	-3%	-$428K	0.42%	41
2025 Q4	$12M	Buy	338,065 +37,938	+13%	+$1.07M	0.41%	39
2025 Q3	$4.31M	Sell	300,127 -5,488	-2%	-$65K	0.16%	165
2025 Q2	$2.19M	Buy	305,615 +3,134	+1%	+$17.4K	0.09%	297
2025 Q1	$1.81M	Buy	302,481 +27,189	+10%	+$213K	0.08%	300
2024 Q4	$2.15M	Buy	275,292 +103,293	+60%	+$1.03M	0.1%	271
2024 Q3	$1.86M	Buy	171,999 +44,287	+35%	+$431K	0.09%	297
2024 Q2	$1.08M	Buy	+127,712	New	+$969K	0.06%	405

Other funds holding COGT

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

DACS

Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return

Hennion & Walsh Asset Management's COGT Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Cogent Biosciences (COGT) stake by 60% in Q2 2026, selling an estimated $6.81M and leaving 131,775 shares worth $5.1M. The position accounts for 0.15% of the portfolio, ranked #189.

Hennion & Walsh Asset Management first reported a position in COGT in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.6M in Q1 2026. 32 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

Hennion & Walsh Asset Management held 131,775 shares of Cogent Biosciences worth $5.1M as of Q2 2026.
Hennion & Walsh Asset Management sold 194,697 Cogent Biosciences shares in Q2 2026, an estimated $6.81M.
Cogent Biosciences made up 0.15% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #189 holding.
Hennion & Walsh Asset Management first reported a position in Cogent Biosciences in Q2 2024 and has held it in 9 quarters since.
Hennion & Walsh Asset Management's Cogent Biosciences position peaked at $12.6M in Q1 2026.
32 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.